Cytokinetics CYTK Earnings Call Transcripts

NASDAQ CYTK
$56.18 +1.04 (+1.89%)
At close: Nov 10, 2026 · 4:00 PM EST
13 earnings calls on file for Cytokinetics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Cytokinetics Q3 2026 Earnings Call

Nov 4, 2026 9,598 words · 42 min read
  • Robert I. BlumPresident and Chief Executive Officer
  • Andrew CallosExecutive Vice President and Chief Commercial Officer
  • Fady MalikExecutive Vice President of Research and Development
  • Stephen HeitnerSenior Vice President and Chief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Cytokinetics Earnings Call Transcripts

Calls13
LatestNov 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 13 Cytokinetics transcripts Register to get access to Cytokinetics’s earnings call transcripts.